title: An aggressive signet ring cell carcinoma of the prostate in a Japanese man.
abstract: Signet ring cell carcinoma (SRCC) of the prostate is rare, with approximately 100 case reports to date. Here we report a very aggressive case of SRCC of the prostate in a Japanese man. The patient received estramustine, docetaxel, and carboplatin combination chemotherapy, followed by TS-1 and CPT-11 combination therapy. Unfortunately, the disease progressed, and he died of general metastatic disease treated over 16 month with systemic chemotherapy.
authors: Oyokyo Kidney Research Institute, Hirosaki Hospital, Hirosaki, Japan.
authors: Yasuhiro
authors: Y
authors: Hashimoto
authors: Kengo
authors: K
authors: Imanishi
authors: Akiko
authors: A
authors: Okamoto
authors: Atsushi
authors: A
authors: Sasaki
authors: Hisao
authors: H
authors: Saitoh
authors: Ryuichi
authors: R
authors: Wada
authors: Hayato
authors: H
authors: Yamamoto
authors: Takuya
authors: T
authors: Koie
authors: Chikara
authors: C
authors: Ohyama